论文部分内容阅读
This study sought to observe the effect of levetiracetam therapy for dyskinetic cerebral palsy.We selected patients with dyskinetic cerebral palsy randomly (outpatients and hospital patients from the Department of Pediatric Neurology of the First Hospital of Jilin University in China), including four boys and six girls, aged 11 months to 4.5 years old (mean age 20.9 ± 13.1 months).